Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Simple answer to you biopharm, Look at STOCK PRICE and VOLUME. Art Levinson has much more important things to do than play chess with BP over little PPHM. In addition MSK is probably doing thousands of trials for BPs and that is where it's bread and butter comes from not little PPHM. PPHM had 2 clinical trials to showcase Bavi and it failed. There are hundreds of little biotechs like PPHM just in California alone.
Astra Zeneca came, let their scientist learn all they could about Bavi and now it is gone.
In English, Does that mean, PPHM work or no work
I think Merck's CEO just thanked Garnick for his great regulatory advises and invited him for a nice cruise on his yacht
Garnick is a CONSULTANT Period
My self imposed time limit on this board is over for today. Have a great day all.
Carboat, absolutely right. By being played with, I meant we should be over a lousy $1. I don't think you can buy a burger with a $1 now a days.
Just think, we are going to start a couple Phase I studies sometime Next Year. Do you think any BP is rushing PPHM thru. IMO, they are not until they are ready to do so based on their own I/O agenda. The sad thing is that we have a management team that does not give a damn about the above.
Right now the BPs are competing against each other and as you see more and more of their drugs are getting approved and generating billions. Why would they want to bring PPHM in the equation NOW. I think MSK and NCCA are keeping them updated on Bavi on regular basis and will tell them when to move in and that is not before April for sure. JUST THINK:
Stoxx1, You have every right to be optimistic since you just got in. I have been here for 17 years and now holding a 35 cent stock. Our situation as far as PPHM goes is very different and that is what the new comers should realize.
Biopharm, As you know, and you just gave the example of stock going up to $3, this stock is being played with by forces outside of any one of us control. As such, there is no reason that these forces will not force a Reverse Split on it. I don't know much about stock market but may be it is in the benefit of the BP or stock manipulator for this stock to split. Any enlightenment in this area will be greatly appreciated.
CP, regarding "profitablility" in 21 months, First, I will not hold my breath on that one because as you know Avid II was 6 months late and I still am not sure if they are generating any real revenue. Secondly, with Big Pharma conducting thousands of immuno combo's who knows what they will come up with in 21 months. They control the System and we all know that. With regards to PPHM and sentiment of some on this board, If you wait long enough, I suppose metal rocks turns into gold also. I just want to keep things balanced on this board.
No Approval or Partner = No Rise in Share Price = RS
Very Simple. You all Enjoy the weekend.
PPHM board is already becoming, "PPHM the best manufacturing company around". lol
I meant to say Biopharm and not Biogen. You caught me in the middle of a major project. Have a nice weekend.
Biogen, my post that you asked about goes back 7 years to the day (10/15/2009). Is that coincidence or do you have some kind of supernatural searching powers :)
No Biopharm, I never worked for a Bp. just small to medium size biotehs that you listed. I worked on Herceptin that Garnick talks about from phase I all the way to phase III
Senrex, What a GREAT way to put it. Have a great life FELLOW long
Biopharm buddy, by the time all of this happens, you are not going to have any shares left. Happy weekend to all.
Garnick is a multi millionaire (thanks to Roche) CONSULTANT that probably works for a lot of BPs that are trying to screw PPHM. If he would have filed for BTD with the 85% responders with 3 complete responders breast cancer study, the stock would have been over $1 now. Does Joe Shan know what happened to those patients. BIG NO
Bye Bye CP. See you on the flip side
Microsoft of Biotech in 10 yrs
It is being held down, it has been held down, it will be held down. There is not a reason for it not to be held down and keep being held down for as long as we all lose our money. Move on
Remember this fellow longs:
No Partner or Approval = No Rise in Share Price
I have been saying this for years and I didn't have to type two page posts to say it.
Short, Simple, Realistic
CP, with all due respect, just read your conclusion. I think in GENERAL you are saying everything is still positive and we are on the right track but it just takes longer for them to achieve it and for us to talk about it. But be happy because we will be profitable in 2 years. I think I have proved my kicking the can down the road in your case. Why do you spend hours thinking what to type in long posts backing PPHM BOD ?? !!. You know you can make a lot of money doing consulting for a BP ;)
Wasn't somebody here saying that they are just doing Data Mining ? That was a good call
That would be a disgrace to Dr. Thorpe. The greatest and humblest man you ever meet. Hopefully he is partying in heaven and not watching PPHM perform
Loof man, a positive spin could be the BOD coming to their senses and selling 40% of the company to a BP like Genentech did with Roche and IDEC did with Genentech ( I have been saying this for years now). By the way,they still call Genentech, Genentech today and not Roche
Trado, Hope so, I have been waiting to see the light at the end of the tunnel for 17 years
The BOD just received a Few thousand dollars for what you heard and the few questions that they will answer and then they get to enjoy the sunny California.
CP, ok lets forget about kicking the can ! Is it fair to say that, lets see what the BOD does in the next 6 months with regards to:
1) filling a BLA
2) Partnering with a BP based on all the current/future I/O data
3) Waiting till the end (April 2017) to do a RS
4) Adding an MD or PHD with industry experience to the BOD
Until then whatever I say will be out of frustration !
Can we have an MD or PHD on the BOD of Peregrine PHARMACEUTICALS Pretty Please
CP,
Cj, Sorry if I misunderstood. eom
Great idea CJ. Lets find that "somebody" that is willing to screen 6000 to try chemo again for another probably 5 years
Kicking the can down the road as usual
Goodjohn, because it has been navigated by a over paid Investor banker BOD. Imagine if we partnered with a BP (Roche, Merck, Bristol, Astra etc.) after our phase II study in 2012 when I/O was being borned. And we have posters standing up for them here all day long. It is always about them knowing "something" that they cannot share with us yet !!
I am sure Peregrine is in the process of asking Watson about such medical device !!
ebo73, I also got to meet the late Dr. Thorpe and he and his science are the only reason I am here today. The joke part is that IMO, he would have liked Bavi to be running in hundreds of trials in thousands of dying patients by a Major BP that knows what they are doing. Oh, and don't forget with an MD or PHD on their board
north, more than half of 50 or 60 people that you see in ASM are the PPHM employees, lawyers, outside accountants, etc. There is nothing wrong with them talking about clinical trials but they should be able to tell what happened to 85% breast cancer responders with a few complete responders.